Barbara Duncan
DirectoratAtea Pharmaceuticals· In proxies 2023–2025
Barbara Duncan sits on 9 public boards.
Experience
- Atea PharmaceuticalsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -2%
- Halozyme, Inc.Public company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Fusion Pharmaceuticals Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- Ovid Therapeutics, Inc.Public company · 9 yr
- Director2017 – Present · 9 yrNo stock prices for these years
- Adaptimmune TherapeuticsPublic company · 7 yr
- Director2016 – 2023 · 7 yrNo stock prices for these years
- Jounce Therapeutics, Inc.Public company · 7 yr
- Director2016 – 2023 · 7 yrNo stock prices for these years
- ObsEva S.A.Public company · 5 yr
- Director2016 – 2021 · 5 yrNo stock prices for these years
- Immunomedics, Inc.Public company · 1 yr
- Director2019 – 2020 · 1 yrNo stock prices for these years
- Aevi Genomic Medicine, Inc.Public company · 5 yr
- Director2015 – 2020 · 5 yrNo stock prices for these years
- Innoviva, Inc.Public company · 2 yr
- Director2016 – 2018 · 2 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?